A cytokine profile of normal and malignant ovary

Cytokine

Volumn 8, Issue 7, 1996, Pages 578-585

  Burke, Frances ^a   Relf, Michele ^a   Negus, Rupert ^a   Balkwill, Frances ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Autocrine loops; Cytokine network; Ovarian cancer; RT PCR; Xenografts

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 4 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; RANTES; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY; OVARY CANCER; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR XENOGRAFT;

EID: 0030198856     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0077     Document Type: Article

References (34)

1. 1. Gutterman JU (1994) Cytokine therapeutics: lessons from Interferon α. Proc Natl Acad Sci USA 91:1198-1205.
2. 2. Balkwill FR (1994) Cytokine therapy of cancer. The importance of knowing the context. Eur Cytokine Netw 5:379-384.
3. 3. Wiener JR, Berchuck A, Bast RC Jr. (1992) Biology and therapy with biologic agents in gynecologic cancer. Curr Sci 4:946-954.
4. 4. Henriksen R, Funa K, Wilander E, Backstrom T, Ridderheim M, Oberg K (1993) Expression and prognositic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res 53:4550-4554
5. 5. Baiocchi G, Kavanagh KJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R (1991) Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 67:990-996.
6. 6. Morishige K-I, Kurachi H, Amemiya K, Fujita Y, Yamamoto T, Miyake A, Tanizawa O (1991) Evidence for the involvement of transforming growth factor-α and epidermal growth factor receptor authocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res 51:5322-5328.
7. 7. Naylor MS, Stamp GWH, Foulkes WD, Eccles D, Balkwill FR (1993) Tumor necrosis factor and its receptors in human ovarian cancer: potential role in disease progression. J Clin Invest 91:2194-2206.
8. 8. Negus RPM, Stamp GWH, Relf MG, Burke F, Malik STA, Bernasconi S, Allavena P, Sozzani S, Mantovani A, Balkwill FR (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391-2396.
9. 9. Langdon SP, Lawrie SS, Hay FG, Hawkes MM, McDonald A, Hayward IP, Schol DJ, Hilgers J, Leonard RCF, Smyth JF (1988) Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res 48:6166-6172.
10. 10. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogana M, Green WR, Ozols RF (1983) Characterisation of human ovarian carcinoma cell line (NIH;OVCAR-3) with androgen and estrogen receptors. Cancer Res 43:5279-5289.
11. 11. Ward BG, Wallace K, Shepherd JH, Balkwill FR (1987) Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res 47:2662-2667.
12. 12. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
13. 13. Maas RA, Dullens HFJ, De Jong WH, Den Otter W (1989) Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2. Cancer Res 49:7037-7040.
14. 13. Puissant C, Houdebein LM (1990) An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 8:148-149.
15. 14. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M (1994) Expression of cytokine/growth factors and their receptors in human melanona and melanocytes. Int J Can 56:853-857.
16. 15. Hosaka ST, Akahoshi T, Wada C and Kondo H (1994) Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 97:451-457.
17. 16. Southern E (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503.
18. 17. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1191-1195.
19. 18. Feinberg BB, Vogelstein (1984) Addendum. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137:266-267
20. 19. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R (1994) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Nat Cancer Inst 86:1234-1238.
21. 20. Baserga R, Sell C, Porcu P and Rubini M (1994) The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif 27:63-71.
22. 21. Leung BS, Stout LE, Shaskan EG, Thompson RA (1992) Differential induction of indoleamine-2,3-dioxygenase (IDO) by interferon-γ in human gynecologic cancer cells. Cancer Lett 66:77-81.
23. 22. Malik STA, Knowles RG, East N, Lando D, Stamp G, Balkwill FR (1991) Antitumor activity of γ-interferon in ascitic and solid tumor models of human ovarian cancer. Cancer Res 51:6643-6649.
24. 23. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M (1993) Immune response in mice that lack the interferon γ receptor. Science 259:1742-1745.
25. 24. Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramakrishnan S (1993) Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 72:2433-2440.
26. 25. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 9:617-648.
27. 26. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro, LA, Elner VM, Elner SG, Stricter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801.
28. 27. Miller MD, Krangel MS (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46.
29. 28. Haskill S, Becker S, Fowler W, Walton L (1982) Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br J Cancer 45:728-736.
30. 29. Yasamura S, Lin W-C, Weidmann E, Hebda P, Whiteside TL (1994) Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. Int J Cancer 59:225-234.
31. 30. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD (1994) Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-706.
32. 31. Hill CSR and Treisman J (1995) Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211.
33. 32. Topp MS, Papadimitriou CA, Eitelbach F, Koenigsmann M, Oelmann E, Koehler B, Oberberg D, Reufi B, Stein H, Eckhard T, Berdel WE (1995) Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res 55:2173-2176.
34. 33. Merlo A, Juretic J, Zuber M, Filgueira L, Luscher U, Caetano V, Ulrich J, Gratzl O, Heberer M, Spagnoli GC (1993) Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns. Eur J Cancer 29:2118-2125.